Picture of Climb Bio logo

CLYM — Climb Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Eliem Therapeutics Reports Q3 Financial And Business Highlights

Nov 8 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS REPORTS THIRD QUARTER FINANCIAL AND
BUSINESS
HIGHLIGHTS
    * ELIEM THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.70

Source text for Eikon:  ID:nGNX2RYCHg 
Further company coverage:  ELYM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Climb Bio

See all news